Does SECUKINUMAB Cause Porphyria acute? 241 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 241 reports of Porphyria acute have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.2% of all adverse event reports for SECUKINUMAB.
241
Reports of Porphyria acute with SECUKINUMAB
0.2%
of all SECUKINUMAB reports
224
Deaths
240
Hospitalizations
How Dangerous Is Porphyria acute From SECUKINUMAB?
Of the 241 reports, 224 (92.9%) resulted in death, 240 (99.6%) required hospitalization, and 241 (100.0%) were considered life-threatening.
Is Porphyria acute Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 241 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Porphyria acute?
GIVOSIRAN (381)
RITUXIMAB (265)
DICLOFENAC (262)
LEFLUNOMIDE (249)
TOCILIZUMAB (243)
METHOTREXATE (238)
ACETAMINOPHEN (237)
ADALIMUMAB (236)
PREDNISONE (227)
ALENDRONATE (225)
Which SECUKINUMAB Alternatives Have Lower Porphyria acute Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG